Cannabis and cannabinoid medications for the treatment of chronic orofacial pain: A scoping review
Objectives: To collate and summarize existing evidence for the use of cannabis and cannabinoids to treat chronic orofacial pain (COP) by oral and maxillofacial surgeons (OMFS), oral medicine specialists (OMS), and orofacial pain specialists (OPS). Data: We systematically screened for sources includi...
| Published in: | Dentistry Review |
|---|---|
| Main Authors: | Jory Longworth, Michael Szafron, Amanda Gruza, Keith Da Silva |
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2023-03-01
|
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2772559623000019 |
Similar Items
Indications and administration practices amongst medical cannabis healthcare providers: a cross-sectional survey
by: Jamie Corroon, et al.
Published: (2019-12-01)
by: Jamie Corroon, et al.
Published: (2019-12-01)
Consensus recommendations on dosing and administration of medical cannabis to treat chronic pain: results of a modified Delphi process
by: Arun Bhaskar, et al.
Published: (2021-07-01)
by: Arun Bhaskar, et al.
Published: (2021-07-01)
Cannabis and the Anxiety of Fragmentation—A Systems Approach for Finding an Anxiolytic Cannabis Chemotype
by: Brishna S. Kamal, et al.
Published: (2018-10-01)
by: Brishna S. Kamal, et al.
Published: (2018-10-01)
Edible cannabis for chronic low back pain: associations with pain, mood, and intoxication
by: Samantha N. Melendez, et al.
Published: (2024-09-01)
by: Samantha N. Melendez, et al.
Published: (2024-09-01)
Cannabinoids—Perspectives for Individual Treatment in Selected Patients: Analysis of the Case Series
by: Michał Graczyk, et al.
Published: (2022-08-01)
by: Michał Graczyk, et al.
Published: (2022-08-01)
Medical Cannabis Received by Patients According to Qualifying Condition in a US State Cannabis Program: Product Choice, Dosing, and Age-Related Trends
by: Xintian Lyu, BS, et al.
Published: (2023-01-01)
by: Xintian Lyu, BS, et al.
Published: (2023-01-01)
Impact of N, P, K, and Humic Acid Supplementation on the Chemical Profile of Medical Cannabis (Cannabis sativa L)
by: Nirit Bernstein, et al.
Published: (2019-06-01)
by: Nirit Bernstein, et al.
Published: (2019-06-01)
Cannabis, a cause for anxiety? A critical appraisal of the anxiogenic and anxiolytic properties
by: Lara Sharpe, et al.
Published: (2020-10-01)
by: Lara Sharpe, et al.
Published: (2020-10-01)
Cannabinoids—Multifunctional Compounds, Applications and Challenges—Mini Review
by: Dominik Duczmal, et al.
Published: (2024-10-01)
by: Dominik Duczmal, et al.
Published: (2024-10-01)
Evaluating Growth, Biomass and Cannabinoid Profiles of Floral Hemp Varieties under Different Planting Dates in Organic Soils of Florida
by: Saroop S. Sandhu, et al.
Published: (2022-11-01)
by: Saroop S. Sandhu, et al.
Published: (2022-11-01)
The roles of cannabis potency and gender in cannabis dependence and anxiety in recent cannabis users with trauma exposure histories
by: T. Snooks, et al.
Published: (2025-02-01)
by: T. Snooks, et al.
Published: (2025-02-01)
The Use of Cannabinoids to Treat Insomnia
by: V. Kutniauskaitė, et al.
Published: (2024-12-01)
by: V. Kutniauskaitė, et al.
Published: (2024-12-01)
Biological Activity of <i>Cannabis sativa</i> L. Extracts Critically Depends on Solvent Polarity and Decarboxylation
by: Guillermo Moreno-Sanz, et al.
Published: (2020-10-01)
by: Guillermo Moreno-Sanz, et al.
Published: (2020-10-01)
The Effect of Harvest Date on Temporal Cannabinoid and Biomass Production in the Floral Hemp (<i>Cannabis sativa</i> L.) Cultivars BaOx and Cherry Wine
by: Eric R. Linder, et al.
Published: (2022-10-01)
by: Eric R. Linder, et al.
Published: (2022-10-01)
A One-Step Grafting Methodology Can Adjust Stem Morphology and Increase THCA Yield in Medicinal Cannabis
by: Sarah Jane Purdy, et al.
Published: (2022-03-01)
by: Sarah Jane Purdy, et al.
Published: (2022-03-01)
Medical Cannabis in Pediatric Oncology: Friend or Foe?
by: Megan Malach, et al.
Published: (2022-03-01)
by: Megan Malach, et al.
Published: (2022-03-01)
Editorial: Therapeutic potential of cannabinoids: from health to disease
by: Évila Lopes Salles, et al.
Published: (2025-02-01)
by: Évila Lopes Salles, et al.
Published: (2025-02-01)
A comparative phytocannabinoid profiling of resin from five hemp (Cannabis sativa L.) cultivars from central-northern Morocco
by: Ismail El Bakali, et al.
Published: (2025-09-01)
by: Ismail El Bakali, et al.
Published: (2025-09-01)
Cannabinoids in Late Life Parkinson’s Disease and Dementia: Biological Pathways and Clinical Challenges
by: Alana C. Costa, et al.
Published: (2022-11-01)
by: Alana C. Costa, et al.
Published: (2022-11-01)
Driving-related behaviors, attitudes, and perceptions among Australian medical cannabis users: results from the CAMS 20 survey
by: Thomas R. Arkell, et al.
Published: (2023-09-01)
by: Thomas R. Arkell, et al.
Published: (2023-09-01)
Oral Tetrahydrocannabinol (THC):Cannabinoid (CBD) Cannabis Extract Adjuvant for Reducing Chemotherapy-Induced Nausea and Vomiting (CINV): A Randomized, Double-Blinded, Placebo-Controlled, Crossover Trial
by: Sukpiriyagul A, et al.
Published: (2023-08-01)
by: Sukpiriyagul A, et al.
Published: (2023-08-01)
Therapeutic Potential of Cannabis: A Comprehensive Review of Current and Future Applications
by: Zach J. Leinen, et al.
Published: (2023-09-01)
by: Zach J. Leinen, et al.
Published: (2023-09-01)
The impact of cannabis on endurance and performance of athletes - risks and benefits - a literature review
by: Paweł Nojek, et al.
Published: (2024-12-01)
by: Paweł Nojek, et al.
Published: (2024-12-01)
Systematic review of drug-drug interactions of delta-9-tetrahydrocannabinol, cannabidiol, and Cannabis
by: Rahul Nachnani, et al.
Published: (2024-05-01)
by: Rahul Nachnani, et al.
Published: (2024-05-01)
The Effect of Cannabis-Based Medicine on Neuropathic Pain and Spasticity in Patients with Multiple Sclerosis and Spinal Cord Injury: Study Protocol of a National Multicenter Double-Blinded, Placebo-Controlled Trial
by: Julie Schjødtz Hansen, et al.
Published: (2021-09-01)
by: Julie Schjødtz Hansen, et al.
Published: (2021-09-01)
Simultaneous Quantification of 17 Cannabinoids in Cannabis Inflorescence by Liquid Chromatography-Mass Spectrometry
by: Amitha K. Hewavitharana, et al.
Published: (2022-03-01)
by: Amitha K. Hewavitharana, et al.
Published: (2022-03-01)
The potential neuroprotective effects of cannabinoids against paclitaxel-induced peripheral neuropathy: in vitro study on neurite outgrowth
by: Ioana Creanga-Murariu, et al.
Published: (2024-06-01)
by: Ioana Creanga-Murariu, et al.
Published: (2024-06-01)
<i>Cannabis Sativa</i> Revisited—Crosstalk between microRNA Expression, Inflammation, Oxidative Stress, and Endocannabinoid Response System in Critically Ill Patients with Sepsis
by: Anca Raluca Dinu, et al.
Published: (2020-01-01)
by: Anca Raluca Dinu, et al.
Published: (2020-01-01)
<i>Cannabis</i> Bioactive Compound-Based Formulations: New Perspectives for the Management of Orofacial Pain
by: Giuseppina Crescente, et al.
Published: (2022-12-01)
by: Giuseppina Crescente, et al.
Published: (2022-12-01)
Medical Cannabis in Children
by: Adi Aran, et al.
Published: (2020-01-01)
by: Adi Aran, et al.
Published: (2020-01-01)
Case report: Cannabinoid therapy for discoid lupus erythematosus in a dog
by: Maria Eduarda Schmitz da Silva, et al.
Published: (2024-02-01)
by: Maria Eduarda Schmitz da Silva, et al.
Published: (2024-02-01)
The use of cannabinoid compounds in therapy in children - future or threat?
by: Joanna Cieszkowska, et al.
Published: (2023-05-01)
by: Joanna Cieszkowska, et al.
Published: (2023-05-01)
The cannabinoids – important therapeutic approach in the field of oncology
by: Nicoleta Mirela Blebea, et al.
Published: (2021-06-01)
by: Nicoleta Mirela Blebea, et al.
Published: (2021-06-01)
The effects of standardized cannabis products in healthy volunteers and patients: a systematic literature review
by: Nadia A. Leen, et al.
Published: (2024-10-01)
by: Nadia A. Leen, et al.
Published: (2024-10-01)
Cannabis-Based Products for the Treatment of Skin Inflammatory Diseases: A Timely Review
by: Ana M. Martins, et al.
Published: (2022-02-01)
by: Ana M. Martins, et al.
Published: (2022-02-01)
Cannabis, Cannabidiol Oils and Tetrahydrocannabinol—What Do Veterinarians Need to Know?
by: Nancy De Briyne, et al.
Published: (2021-03-01)
by: Nancy De Briyne, et al.
Published: (2021-03-01)
PRELIMINARY FINDINGS ON THE EFFECT OF Trichoderma harzianum ON THE CANNABINOIDS PRODUCTION IN MEDICINAL Cannabis sativa CLONES.
by: Cecilia Monaco, et al.
Published: (2025-07-01)
by: Cecilia Monaco, et al.
Published: (2025-07-01)
The Transdermal Delivery of Therapeutic Cannabinoids
by: Haleh Mahmoudinoodezh, et al.
Published: (2022-02-01)
by: Haleh Mahmoudinoodezh, et al.
Published: (2022-02-01)
High-Performance Liquid Chromatography with DAD Detection for the Determination of Cannabinoids in Commercial Veterinary CBD Oil
by: Zehra Hajrulai-Musliu, et al.
Published: (2024-12-01)
by: Zehra Hajrulai-Musliu, et al.
Published: (2024-12-01)
Assessing the neuroprotective benefits of Cannabis sativa in epilepsy management
by: Mohd.Shoeb Abdul Mukhtar, et al.
Published: (2025-03-01)
by: Mohd.Shoeb Abdul Mukhtar, et al.
Published: (2025-03-01)
Similar Items
-
Indications and administration practices amongst medical cannabis healthcare providers: a cross-sectional survey
by: Jamie Corroon, et al.
Published: (2019-12-01) -
Consensus recommendations on dosing and administration of medical cannabis to treat chronic pain: results of a modified Delphi process
by: Arun Bhaskar, et al.
Published: (2021-07-01) -
Cannabis and the Anxiety of Fragmentation—A Systems Approach for Finding an Anxiolytic Cannabis Chemotype
by: Brishna S. Kamal, et al.
Published: (2018-10-01) -
Edible cannabis for chronic low back pain: associations with pain, mood, and intoxication
by: Samantha N. Melendez, et al.
Published: (2024-09-01) -
Cannabinoids—Perspectives for Individual Treatment in Selected Patients: Analysis of the Case Series
by: Michał Graczyk, et al.
Published: (2022-08-01)
